Skip to content

Drug interactions

Fedratinib + Hydrochlorothiazide-losartan

Severity: Minor

Fedratinib and Hydrochlorothiazide-losartan: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

The warning concerns dual CYP3A4 and CYP2C19 inhibitors, and losartan is not such an inhibitor. A clinically important rise in fedratinib exposure is not expected.

What this interaction means in plain words

Fedratinib and Hydrochlorothiazide-losartan have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Fedratinib belongs to Oncology; Hydrochlorothiazide-losartan belongs to Cardiovascular.

Evidence level: Low

Why it happens

No established pharmacokinetic mechanism; losartan is not a recognised inhibitor of CYP3A4 or CYP2C19.

What to do

No dose adjustment is required; monitor for fedratinib toxicity including gastrointestinal effects and anaemia as usual.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fedratinib and Hydrochlorothiazide-losartan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Fedratinib with Hydrochlorothiazide-losartan?

MediHelp rates the interaction as minor. Fedratinib and Hydrochlorothiazide-losartan have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. The warning concerns dual CYP3A4 and CYP2C19 inhibitors, and losartan is not such an inhibitor. A clinically important rise in fedratinib exposure is not expected.

How serious is the interaction between Fedratinib and Hydrochlorothiazide-losartan?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is required; monitor for fedratinib toxicity including gastrointestinal effects and anaemia as usual.

What other medicines interact with Hydrochlorothiazide-losartan?

MediHelp also lists interactions of Hydrochlorothiazide-losartan with, for example, Aliskiren, Dofetilide, Sparsentan. The full list is on the Hydrochlorothiazide-losartan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in